Multivitamin use after diagnosis and prostate cancer survival among men with nonmetastatic prostate cancer.

ABSTRACT:

Background

Multivitamin use is common among cancer patients. Whether post-diagnostic multivitamin supplementation is beneficial for prostate cancer survival is largely unknown, and some evidence even suggests potential harm.

Methods

We prospectively assessed post-diagnostic multivitamin use in relation to prostate cancer survival among 4756 men with nonmetastatic prostate cancer at diagnosis in the Health Professionals Follow-up Study (1986-2016). Cox regression models were used to evaluate the association between post-diagnostic multivitamin use and frequency and risk of lethal prostate cancer (distant metastases or prostate cancer-specific death) and all-cause mortality.

Results

We observed 438 lethal prostate cancer and 2609 deaths during a median follow-up of 11 y

SUBMITTER: Zhang Y 

PROVIDER: S-EPMC11091183 | biostudies-literature | 2024 Jun

REPOSITORIES: biostudies-literature